全身利多卡因未能改善后路脊柱融合术后的吗啡用量、恢复及生活质量:双盲随机安慰剂对照试验
该前瞻性随机双盲安慰剂对照试验纳入70例后路脊柱融合术患者,比较围术期全身利多卡因输注与安慰剂对术后24小时吗啡用量的影响。结果显示利多卡因组与安慰剂组吗啡用量无显著差异,术后疼痛程度、48和72小时吗啡用量、恶心呕吐发生率、炎症指标、肠道功能恢复时间、住院时长及生活质量亦无差异。
要点
- 全身利多卡因未减少后路脊柱融合术后24小时吗啡用量。
- 利多卡因对术后疼痛、恢复指标及生活质量均无改善。
- 在阿片类麻醉方案基础上加用利多卡因无额外镇痛获益。
核心结论
- 在后路脊柱融合术中,全身利多卡因加入阿片类麻醉方案未提供镇痛获益。
研究设计与样本
- 前瞻性、随机、双盲、安慰剂对照临床试验,纳入70例后路脊柱融合术患者。
主要发现
- 术后24小时吗啡用量利多卡因组为48(23)mg,安慰剂组为51(19)mg,P=0.22。
- 两组在术后疼痛程度、48和72小时吗啡用量、术后恶心呕吐发生率、围术期炎症、肠道功能恢复时间、住院时长及生活质量方面均无差异。
关键数值与推荐
- 利多卡因组:麻醉诱导时静脉注射1.5 mg kg-1,随后以1.5 mg kg-1 h-1输注至麻醉后监护室后6小时。
- 安慰剂组:等体积生理盐水。
- 术后疼痛采用患者自控静脉吗啡治疗。
临床怎么用
- 对于后路脊柱融合术患者,不建议为减少术后阿片类用量而常规围术期输注全身利多卡因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND.: It is inconclusive whether the perioperative administration of systemic lidocaine provides effective postoperative analgesia and enhances recovery in major orthopaedic surgery. We hypothesised that in adolescent and adult patients undergoing posterior spinal arthrodesis, a perioperative lidocaine infusion would reduce opioid requirements during the first 24 postoperative h. METHODS.: 70 patients undergoing posterior arthrodesis were enrolled in this prospective, randomised, double-blind, placebo-controlled clinical trial. Patients received total i.v. anaesthesia with propofol and remifentanil and were randomized to an adjuvant therapy with either lidocaine [i.v.-bolus injection of 1.5 mg kg -1 at induction of anaesthesia, followed by an infusion of 1.5 mg kg -1 h -1 which was continued until six h after arrival at the post-anaesthesia care unit] or placebo (equal volumes of saline). Postoperative pain was treated with patient-controlled i.v. morphine. Primary endpoints of this study were morphine requirements in the first postoperative 24 h. RESULTS.: Systemic lidocaine did not decrease morphine requirements in the first 24 postoperative h [lidocaine-group: 48 (23) mg (mean( sd )) vs placebo-group: 51(19) mg, P = 0.22]. Likewise, groups were not different with respect to the severity of postoperative pain, morphine consumption after 48 and 72 h, incidence of postoperative nausea and vomiting, perioperative inflammation, time to recovery of intestinal function, hospital length of stay, and quality of life (assessed preoperatively and one month postoperatively using the SF-12 physical and mental composite scores). CONCLUSIONS.: In our study, systemic lidocaine had no analgesic benefits in posterior arthrodesis when added to an opioid-based anaesthetic regimen. CLINICAL TRIAL REGISTRATION.: Eudra CT 2012-005264-98.
引用
- Dewinter G, Moens P, Fieuws S, et al. Systemic lidocaine fails to improve postoperative morphine consumption, postoperative recovery and quality of life in patients undergoing posterior spinal arthrodesis. A double-blind, randomized, placebo-controlled trial. Br J Anaesth. 2017. PMID: 28403408. doi:10.1093/bja/aex038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。